Zurueck zur Suche

Reporte zur Charge U016976

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
UT 2 WA 1 MT 1 AZ 1 NM 1 NV 1

VAERS 2202430

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

mild
Staat
WA
Alter
5,0
Geschlecht
M
Eingang
28.03.2022
Impfdatum
21.03.2022
Beginn
22.03.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Redness and swelling at injection site after administration of vaccines. Pt was seen by provider in clinic, prescribed amoxicillin and diphenhydramine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
multiple food allergies
Andere Medikamente
none
Allergien
cat hair, peanut containing product
Vorherige Impfungen
-

VAERS 2088918

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

mild
Staat
MT
Alter
4,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
31.01.2022
Beginn
31.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site induration Injection site pain Injection site pruritus Injection site warmth

Symptomtext

Patient seen for 4 year WCC 01/31/2022. Caregiver consented to Kinrix, ProQuad, and Influenza vaccines. Patient presented for acute visit 02/03/2022 with mother reporting child having immediate redness to left upper thigh the night after vaccines that increased in redness, warmth, itching, pain, and hardness, in which child was then seen in office with site measuring about 10x14cm and concerns for signs of cellulitis. Patient was treated with oral antibiotic course of Keflex with improvement after beginning course of antibiotic, awaiting follow-up in 1 week to check for resolution.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
No tests or labs ordered.
Aktuelle Erkrankungen
None at time of visit. COVID + 01/17/2022. No other reported illnesses leading up to vaccines.
Vorgeschichte
Generally healthy, being worked up for staring spells as possible seizures as of 4 year WCC.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2483081

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

gering
Staat
AZ
Alter
6,0
Geschlecht
M
Eingang
19.10.2022
Impfdatum
19.10.2022
Beginn
01.10.2022
Tage bis Beginn
-
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

pending

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2449387

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

gering
Staat
UT
Alter
14,0
Geschlecht
F
Eingang
17.09.2022
Impfdatum
27.08.2022
Beginn
27.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional adverse event; a dose of PROQUAD was administered intramuscularly to the patient.; This spontaneous report was received from a medical assistant and refers to a 14-year-old female patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided. On 27-AUG-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (also reported as Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R) conflicting information) at a dose of 0.5 mililiter, lot number U016976 who had been verified to be a valid number, expiration date: 24-NOV-2022, for prophylaxis (strength, frequency and anatomical location were not provided). On the same date, it was reported that the vaccine was administered intramuscularly instead of subcutaneous (incorrect route of product administration). It was reported that the event was noted and informed to the provider and the patient. It was reported that the immunogenicity was achieved, also that there was no ill consequence and that no more future interventions were necessary for the patient (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2410150

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

gering
Staat
UT
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
14.07.2022
Beginn
14.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event

Symptomtext

no adverse event; Caller is a medical assistant who reports that PROQUAD and VARIVAX were inadvertently administered to a patient concomitantly today; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-JUL-2022, the patient was inadvertently vaccinated varicella virus vaccine live (oka/merck) (VARIVAX) (0.5 mL once, lot #U033046, expiration date: 21-OCT-2023) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live(recombinant human albumin (rHA)) (PROQUAD) (0.5 mL, lot #U016976, expiration date: 24-NOV-2022) administered for prophylaxis (strength, anatomical location and route of administration were not provided) (accidental overdose) with sterile diluent (MERCK STERILE DILUENT). The patient had no adverse effects or symptoms from receiving these doses (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2249213

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
23.04.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE information; dose of Proquad administered to an adult; This spontaneous report was received from a pharmacy student referring to an adult patient of unknown gender. No patient's pertinent medical history, concurrent conditions, drug reactions or allergies, nor concomitant therapies were reported. On 22-MAR-2022, the adult patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # U016976, expiration date 24-NOV-2022, 0.5 milliliter, once, (route, anatomical location, and dose number were not reported), as prophylaxis (product administered to patient of inappropriate age). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1845227

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016976

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
05.11.2021
Impfdatum
22.10.2021
Beginn
22.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

PROQUAD was administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 22-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) 0.5 milliliter, lot number U016976, expiration date 24-NOV-2022 (route of administration not reported) for prophylaxis (product storage error). The vaccine underwent a temperature excursion of 10 degrees Farhrenheit fo 6 hours. No previous temperature excursions detected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-